Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus
- PMID: 19165918
- PMCID: PMC2772171
- DOI: 10.1038/ng.200
Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease influenced by genetic and environmental factors. We carried out a genome-wide association scan and replication study and found an association between SLE and a variant in TNFAIP3 (rs5029939, meta-analysis P = 2.89 x 10(-12), OR = 2.29). We also found evidence of two independent signals near TNFAIP3 associated with SLE, including one previously associated with rheumatoid arthritis (RA). These results establish that variants near TNFAIP3 contribute to differential risk of SLE and RA.
Figures

Similar articles
-
The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population.Arthritis Rheum. 2010 Feb;62(2):574-9. doi: 10.1002/art.27190. Arthritis Rheum. 2010. PMID: 20112363
-
TNFAIP3 gene polymorphisms associated with differential susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Korean population.Rheumatology (Oxford). 2014 Jun;53(6):1009-13. doi: 10.1093/rheumatology/ket473. Rheumatology (Oxford). 2014. PMID: 24489017
-
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility.Arthritis Res Ther. 2009;11(2):R42. doi: 10.1186/ar2650. Epub 2009 Mar 17. Arthritis Res Ther. 2009. PMID: 19292917 Free PMC article.
-
Non-major histocompatibility complex rheumatoid arthritis susceptibility genes.Crit Rev Immunol. 2011;31(2):99-114. doi: 10.1615/critrevimmunol.v31.i2.20. Crit Rev Immunol. 2011. PMID: 21542789 Review.
-
Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.Adv Exp Med Biol. 2014;809:163-83. doi: 10.1007/978-1-4939-0398-6_10. Adv Exp Med Biol. 2014. PMID: 25302371 Review.
Cited by
-
A20/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus.Brain Behav Immun Health. 2019 Dec 14;2:100018. doi: 10.1016/j.bbih.2019.100018. eCollection 2020 Feb. Brain Behav Immun Health. 2019. PMID: 38377433 Free PMC article.
-
Let-7 miRNAs Modulate the Activation of NF-κB by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis.PLoS One. 2015 Jun 25;10(6):e0121256. doi: 10.1371/journal.pone.0121256. eCollection 2015. PLoS One. 2015. PMID: 26110642 Free PMC article.
-
TNFSF4 Gene Variations Are Related to Early-Onset Autoimmune Thyroid Diseases and Hypothyroidism of Hashimoto's Thyroiditis.Int J Mol Sci. 2016 Aug 20;17(8):1369. doi: 10.3390/ijms17081369. Int J Mol Sci. 2016. PMID: 27556446 Free PMC article.
-
Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.J Clin Immunol. 2012 Dec;32(6):1287-91. doi: 10.1007/s10875-012-9764-2. Epub 2012 Aug 17. J Clin Immunol. 2012. PMID: 22898832
-
Meta-analysis of two Chinese populations identifies an autoimmune disease risk allele in 22q11.21 as associated with systemic lupus erythematosus.Arthritis Res Ther. 2015 Mar 20;17(1):67. doi: 10.1186/s13075-015-0577-6. Arthritis Res Ther. 2015. PMID: 25880549 Free PMC article.
References
-
- Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum. 2008;58:15–25. - PubMed
-
- Kaslow RA, Masi AT. Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum. 1978;21:473–9. - PubMed
-
- Boone DL, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004;5:1052–60. - PubMed
-
- Wertz IE, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430:694–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R56 AI063274/AI/NIAID NIH HHS/United States
- P30 AR053483/AR/NIAMS NIH HHS/United States
- MH067257/MH/NIMH NIH HHS/United States
- 5F32AR50927/AR/NIAMS NIH HHS/United States
- R01 MH060870/MH/NIMH NIH HHS/United States
- R01 MH059587/MH/NIMH NIH HHS/United States
- MH060879/MH/NIMH NIH HHS/United States
- MH059588/MH/NIMH NIH HHS/United States
- MH59566/MH/NIMH NIH HHS/United States
- R01 AR056768/AR/NIAMS NIH HHS/United States
- MH59587/MH/NIMH NIH HHS/United States
- R01 MH061675/MH/NIMH NIH HHS/United States
- MH061675/MH/NIMH NIH HHS/United States
- R01 AI063274/AI/NIAID NIH HHS/United States
- F32 AR050927/AR/NIAMS NIH HHS/United States
- MH 63420/MH/NIMH NIH HHS/United States
- MH60870/MH/NIMH NIH HHS/United States
- MH59586/MH/NIMH NIH HHS/United States
- 076113/WT_/Wellcome Trust/United Kingdom
- AR043247/AR/NIAMS NIH HHS/United States
- AR052125/AR/NIAMS NIH HHS/United States
- K08 AR002105/AR/NIAMS NIH HHS/United States
- R01 AR052125/AR/NIAMS NIH HHS/United States
- AI063274/AI/NIAID NIH HHS/United States
- R01 MH067257/MH/NIMH NIH HHS/United States
- R01 MH059571/MH/NIMH NIH HHS/United States
- R01 MH059565/MH/NIMH NIH HHS/United States
- MH059565/MH/NIMH NIH HHS/United States
- R01 MH059586/MH/NIMH NIH HHS/United States
- R01 MH059566/MH/NIMH NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R01 MH063420/MH/NIMH NIH HHS/United States
- R01 MH059588/MH/NIMH NIH HHS/United States
- R01 AR043274/AR/NIAMS NIH HHS/United States
- R01 MH060879/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical